tetano
Editor, Senior Moderator
Clin Infect Dis. 2014 Aug 19. pii: ciu664. [Epub ahead of print]
Impact of Influenza B Lineage-level Mismatch between Trivalent Seasonal Influenza Vaccines and Circulating Viruses, 1999-2012.
Heikkinen T1, Ikonen N2, Ziegler T3.
Author information
Abstract
BACKGROUND:
Influenza B virus strains in trivalent influenza vaccines are frequently mismatched to the circulating B strains, but the population-level impact of such mismatches is unknown. We assessed the impact of vaccine mismatch on the epidemiology of influenza B during 12 recent seasonal outbreaks of influenza in Finland.
METHODS:
We analyzed all available nationwide data on virologically confirmed influenza infections in all age groups in Finland between July 1, 1999, and June 30, 2012, with the exclusion of the pandemic season of 2009-2010. We derived data on influenza infections and the circulation of different lineages of B viruses during each season from the Infectious Diseases Register and the National Influenza Center, National Institute for Health and Welfare, Finland.
RESULTS:
A total of 34 788 cases of influenza were recorded. Influenza A accounted for 74.0% and influenza B for 26.0% of all typed viruses. Throughout the 12 seasons, we estimated that 41.7% (3750 of 8993) of all influenza B infections were caused by viruses representing the other genetic lineage than the one in the vaccine. Altogether, opposite-lineage influenza B viruses accounted for 10.8% of all influenza infections in the population, the proportion being highest (16.8%) in children aged 10-14 years and lowest (2.6%) in persons aged 70 years or older.
CONCLUSIONS:
The population-level impact of lineage-level mismatch between the vaccine and circulating strains of influenza B viruses is substantial especially among children and adolescents. The results provide strong support for the inclusion of both influenza B lineages in seasonal influenza vaccines.
? The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
PMID:
25139969
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/25139969
Impact of Influenza B Lineage-level Mismatch between Trivalent Seasonal Influenza Vaccines and Circulating Viruses, 1999-2012.
Heikkinen T1, Ikonen N2, Ziegler T3.
Author information
Abstract
BACKGROUND:
Influenza B virus strains in trivalent influenza vaccines are frequently mismatched to the circulating B strains, but the population-level impact of such mismatches is unknown. We assessed the impact of vaccine mismatch on the epidemiology of influenza B during 12 recent seasonal outbreaks of influenza in Finland.
METHODS:
We analyzed all available nationwide data on virologically confirmed influenza infections in all age groups in Finland between July 1, 1999, and June 30, 2012, with the exclusion of the pandemic season of 2009-2010. We derived data on influenza infections and the circulation of different lineages of B viruses during each season from the Infectious Diseases Register and the National Influenza Center, National Institute for Health and Welfare, Finland.
RESULTS:
A total of 34 788 cases of influenza were recorded. Influenza A accounted for 74.0% and influenza B for 26.0% of all typed viruses. Throughout the 12 seasons, we estimated that 41.7% (3750 of 8993) of all influenza B infections were caused by viruses representing the other genetic lineage than the one in the vaccine. Altogether, opposite-lineage influenza B viruses accounted for 10.8% of all influenza infections in the population, the proportion being highest (16.8%) in children aged 10-14 years and lowest (2.6%) in persons aged 70 years or older.
CONCLUSIONS:
The population-level impact of lineage-level mismatch between the vaccine and circulating strains of influenza B viruses is substantial especially among children and adolescents. The results provide strong support for the inclusion of both influenza B lineages in seasonal influenza vaccines.
? The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
PMID:
25139969
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/25139969